BLMS 0.21 Bloomios, Inc.
| Range: | 1.0E-4-0.0166 | Vol Avg: | 456238 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.09 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Apr 22 2003 | Empoloyees: | 3 | ||
| CUSIP: | 094857109 | CIK: | 0001138608 | ISIN: | US0948571098 | Country: | US |
| CEO: | Mr. Michael Hill | Website: | https://www.bloomios.com | ||||
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow